This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Sg Medical Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Hyeong Sun Kwon: Innovator in Cancer Treatment
Introduction
Hyeong Sun Kwon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of monoclonal antibodies.
Latest Patents
Hyeong Sun Kwon holds a patent for an "Anti-beta 1 integrin humanized antibody, and pharmaceutical composition for treating cancer, comprising same." This invention relates to a monoclonal antibody or fragment that specifically recognizes and binds to beta 1 integrin as an antigen. The pharmaceutical composition developed by Kwon is designed for preventing or treating cancer, utilizing the monoclonal antibody's ability to inhibit the proliferation and angiogenesis of cancer cells while effectively inducing apoptosis.
Career Highlights
Kwon's career is marked by his dedication to advancing cancer therapies. His work has led to the development of innovative solutions that address critical challenges in cancer treatment. He is associated with Sg Medical Inc., where he continues to contribute to groundbreaking research.
Collaborations
Hyeong Sun Kwon collaborates with Ji Chul Lee, enhancing the research and development efforts at Sg Medical Inc. Their partnership focuses on creating effective treatments for cancer patients.
Conclusion
Hyeong Sun Kwon's contributions to cancer treatment through his patented innovations highlight his role as a key figure in medical research. His work continues to inspire advancements in the field of oncology.